Who Paid My Doc
Induction Study #1 - A Phase 3, Multicenter, Rando
Research payments
$804,773
Through program year 2022, $804,773 in research payments was reported against Induction Study #1 - A Phase 3, Multicenter, Rando, across 71 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $112,248 | 8 |
| 2021 | Research | $692,525 | 63 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Keith Sultan Garden City, NY Named on 2 payments
- Rohit Singhania Springfield, MA Named on 2 payments
- Bincy Abraham Houston, TX Named on 2 payments
- Mark Sapienza Englewood, NJ Named on 2 payments
- Carl Dukes San Antonio, TX Named on 2 payments
- Bryan Heath New Smyrna Beach, FL Named on 2 payments
- Nir Modiano Portland, OR Named on 2 payments
- Timothy Ritter Southlake, TX Named on 2 payments
- Kofi Clarke Harrisburg, PA Named on 2 payments
- Deborah Flomenhoft Lexington, KY Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.